PORADOSU ENRIQUE (Chief Science and Business Off) received a stock award from NUVECTIS PHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 1/3/2025ACC: 0001104659-25-000912
Officer· Chief Science and Business Off
Since Feb 2022
+150K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
150K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+150K
Price / share
—
Trade value
—
% of position
10.0%
1/2/2025
1.51M→1.66M
Total
Net shares
+150K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/2/2025 | A · Award | +150K | — | — | 10.0% | 1.51M | 1.66M |
| Total | +150K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported